Skip to Main Content

Author Details

Kasmintan A Schrader
University of British Columbia
2005
96
28
PMIDPaper TitleJournal TitlePublished Year
37821757"I just wanted more": Hereditary cancer syndromes patients' perspectives on the utility of circulating tumour DNA testing for cancer screening.Eur J Hum Genet2024
37821757"I just wanted more": Hereditary cancer syndromes patients' perspectives on the utility of circulating tumour DNA testing for cancer screening.Eur J Hum Genet2024
36660874Development and early-stage evaluation of a patient portal to enhance familial communication about hereditary cancer susceptibility testing: A patient-driven approach.Health Expect2023
378519132023 Canadian Urological Association guideline: Genetic testing in prostate cancer.Can Urol Assoc J2023
37217257A model for the return and referral of all clinically significant secondary findings of genomic sequencing.J Med Genet2023
36797466Defining the heterogeneity of unbalanced structural variation underlying breast cancer susceptibility by nanopore genome sequencing.Eur J Hum Genet2023
36919843How do members of the public expect to use variants of uncertain significance in their health care? A population-based survey.Genet Med2023
36600593Optimising clinical care through <i>CDH1</i>-specific germline variant curation: improvement of clinical assertions and updated curation guidelines.J Med Genet2023
36660874Development and early-stage evaluation of a patient portal to enhance familial communication about hereditary cancer susceptibility testing: A patient-driven approach.Health Expect2023
378519132023 Canadian Urological Association guideline: Genetic testing in prostate cancer.Can Urol Assoc J2023
37217257A model for the return and referral of all clinically significant secondary findings of genomic sequencing.J Med Genet2023
36919843How do members of the public expect to use variants of uncertain significance in their health care? A population-based survey.Genet Med2023
36600593Optimising clinical care through <i>CDH1</i>-specific germline variant curation: improvement of clinical assertions and updated curation guidelines.J Med Genet2023
36797466Defining the heterogeneity of unbalanced structural variation underlying breast cancer susceptibility by nanopore genome sequencing.Eur J Hum Genet2023
34232459Patient ethnicity and cascade genetic testing: a descriptive study of a publicly funded hereditary cancer program.Fam Cancer2022
36240332Recommendations for the implementation of genetic testing for metastatic prostate cancer patients in Canada.Can Urol Assoc J2022
35385106"Game Changer": Health Professionals' Views on the Clinical Utility of Circulating Tumor DNA Testing in Hereditary Cancer Syndrome Management.Oncologist2022
35877228Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer Prevention.Curr Oncol2022
35739291A comprehensive genomic reporting structure for communicating all clinically significant primary and secondary findings.Hum Genet2022
35487723Genetics Adviser: a protocol for a mixed-methods randomised controlled trial evaluating a digital platform for genetics service delivery.BMJ Open2022
35367630The Neoantigen Landscape of the Coding and Noncoding Cancer Genome Space.J Mol Diagn2022
36265114Germline Testing and Somatic Tumor Testing for <i>BRCA1/2</i> Pathogenic Variants in Ovarian Cancer: What Is the Optimal Sequence of Testing?JCO Precis Oncol2022
36777186Parent-of-origin detection and chromosome-scale haplotyping using long-read DNA methylation sequencing and Strand-seq.Cell Genom2022
34232459Patient ethnicity and cascade genetic testing: a descriptive study of a publicly funded hereditary cancer program.Fam Cancer2022
34843087Early-stage economic analysis of research-based comprehensive genomic sequencing for advanced cancer care.J Community Genet2022
35739291A comprehensive genomic reporting structure for communicating all clinically significant primary and secondary findings.Hum Genet2022
35367630The Neoantigen Landscape of the Coding and Noncoding Cancer Genome Space.J Mol Diagn2022
35487723Genetics Adviser: a protocol for a mixed-methods randomised controlled trial evaluating a digital platform for genetics service delivery.BMJ Open2022
35385106"Game Changer": Health Professionals' Views on the Clinical Utility of Circulating Tumor DNA Testing in Hereditary Cancer Syndrome Management.Oncologist2022
36777186Parent-of-origin detection and chromosome-scale haplotyping using long-read DNA methylation sequencing and Strand-seq.Cell Genom2022
36240332Recommendations for the implementation of genetic testing for metastatic prostate cancer patients in Canada.Can Urol Assoc J2022
36265114Germline Testing and Somatic Tumor Testing for <i>BRCA1/2</i> Pathogenic Variants in Ovarian Cancer: What Is the Optimal Sequence of Testing?JCO Precis Oncol2022
35877228Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer Prevention.Curr Oncol2022
34843087Early-stage economic analysis of research-based comprehensive genomic sequencing for advanced cancer care.J Community Genet2022
32895333Rare <i>APC</i> promoter 1B variants in gastric cancer kindreds unselected for fundic gland polyposis.Gut2021
34152087Clinical and cost outcomes following genomics-informed treatment for advanced cancers.Cancer Med2021
34197922Use of Treatment-Focused Tumor Sequencing to Screen for Germline Cancer Predisposition.J Mol Diagn2021
33237632Matching methods in precision oncology: An introduction and illustrative example.Mol Genet Genomic Med2021
32895333Rare <i>APC</i> promoter 1B variants in gastric cancer kindreds unselected for fundic gland polyposis.Gut2021
32892247Beyond medically actionable results: an analytical pipeline for decreasing the burden of returning all clinically significant secondary findings.Hum Genet2021
34397043Integrating Tumor Sequencing Into Clinical Practice for Patients With Mismatch Repair-Deficient Lynch Syndrome Spectrum Cancers.Clin Transl Gastroenterol2021
34537903Patient and public preferences for being recontacted with updated genomic results: a mixed methods study.Hum Genet2021
34397043Integrating Tumor Sequencing Into Clinical Practice for Patients With Mismatch Repair-Deficient Lynch Syndrome Spectrum Cancers.Clin Transl Gastroenterol2021
34537903Patient and public preferences for being recontacted with updated genomic results: a mixed methods study.Hum Genet2021
34152087Clinical and cost outcomes following genomics-informed treatment for advanced cancers.Cancer Med2021
34197922Use of Treatment-Focused Tumor Sequencing to Screen for Germline Cancer Predisposition.J Mol Diagn2021
33237632Matching methods in precision oncology: An introduction and illustrative example.Mol Genet Genomic Med2021
32892247Beyond medically actionable results: an analytical pipeline for decreasing the burden of returning all clinically significant secondary findings.Hum Genet2021
32255556Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening.Cancer Med2020
32028617Oncology Clinic-Based Hereditary Cancer Genetic Testing in a Population-Based Health Care System.Cancers (Basel)2020
  • 1 - 50 of 192

Recommended Authors

Karen Ouyang
Invitae Corporation
Career Start Year 2013
Number of shared co-authors 0
Sarah M Nielsen
Invitae Corporation
Career Start Year 2011
Number of shared co-authors 14
Nicholas Pachter
King Edward Memorial Hospital
Career Start Year 2009
Number of shared co-authors 12
Francine B de Abreu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 0
Sigve Nakken
University of Oslo
Career Start Year 2007
Number of shared co-authors 6
Sarah A Jackson
Robert H Lurie Comprehensive Cancer Center Northwestern University
Career Start Year 2007
Number of shared co-authors 10
Arezou A Ghazani
Brigham and Women's Hospital, USA Harvard Medical School
Career Start Year 2006
Number of shared co-authors 6
Claire Palles
Institute of Cancer and Genomic Sciences, University of Birmingham
Career Start Year 2006
Number of shared co-authors 12
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 20
Matthew B Yurgelun
34Dana-Farber/Brigham and Women's Cancer Center.
Career Start Year 2005
Number of shared co-authors 10
Rebecca Nagy
Guardant Health Inc.
Career Start Year 2004
Number of shared co-authors 5
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 0
Elena M Stoffel
Rogel Cancer Center, University of Michigan ann arbor
Career Start Year 2002
Number of shared co-authors 14
Teresa Ram??n y Cajal
Familial Cancer Clinic, Hospital Sant Pau
Career Start Year 2000
Number of shared co-authors 31
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Career Start Year 1999
Number of shared co-authors 20
Kenna R Mills Shaw
The University of Texas MD Anderson Cancer Center
Career Start Year 1999
Number of shared co-authors 12
Louise Izatt
Guy's and St Thomas' NHS Foundation Trust
Career Start Year 1998
Number of shared co-authors 36
Edward D Esplin
Invitae Corporation
Career Start Year 1998
Number of shared co-authors 6
Dirce Maria Carraro
AC Camargo Cancer Center
Career Start Year 1998
Number of shared co-authors 7
Rebecca Sutphen
College of Medicine, University of South Florida
Career Start Year 1995
Number of shared co-authors 24
Siranoush Manoukian
Fondazione IRCCS Istituto Nazionale dei Tumori
Career Start Year 1993
Number of shared co-authors 41
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 23
Clare Turnbull
Institute of Cancer Research
Career Start Year 1991
Number of shared co-authors 30
Christi J van Asperen
Leiden University Medical Center
Career Start Year 1989
Number of shared co-authors 35
Michael R Stratton
Wellcome Sanger Institute
Career Start Year 1987
Number of shared co-authors 42
Georgia L Wiesner
Vanderbilt Genetics Institute, Vanderbilt University Medical Center
Career Start Year 1986
Number of shared co-authors 10
Rosalind A Eeles
The Institute of Cancer Research
Career Start Year 1982
Number of shared co-authors 48
Heather Thorne
Peter MacCallum Cancer Centre
Career Start Year 1982
Number of shared co-authors 31
Jan Lubinski
Pomeranian Medical University
Career Start Year 1979
Number of shared co-authors 53
Stephen N Thibodeau
Mayo Clinic
Career Start Year 1978
Number of shared co-authors 34

Collaborators

Steven J M Jones
University of British Columbia
Co-authored papers 19
David G Huntsman
University of British Columbia
Co-authored papers 18
Janessa Laskin
Co-authored papers 18
Marco A Marra
University of British Columbia
Co-authored papers 18
Andrew J Mungall
Co-authored papers 12
Richard A Moore
Co-authored papers 11
Raymond H Kim
Cardiac Genome Clinic, The Hospital for Sick Children
Co-authored papers 9
Katherine L Nathanson
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Co-authored papers 8
Robert J Klein
Co-authored papers 8
Janine Senz
University of British Columbia
Co-authored papers 8
Martin R Jones
BC Cancer Research Centre.
Co-authored papers 8
Yussanne Ma
Co-authored papers 8
Caralyn Reisle
University of British Columbia
Co-authored papers 8
Fergus J Couch
Mayo Clinic
Co-authored papers 7
Pardeep Kaurah
University of British Columbia
Co-authored papers 7
Susan M Domchek
Co-authored papers 6
Carolyn Ch'ng
GenomeDx Biosciences Inc.
Co-authored papers 6
Steve E Kalloger
University of British Columbia
Co-authored papers 6
Liying Zhang
The Fifth Affiliated Hospital, Sun Yat-sen University
Co-authored papers 6
Judy E Garber
Dana-Farber Cancer Institute
Co-authored papers 5
June C Carroll
University of Toronto
Co-authored papers 5
Yongjun Zhao
Canada British Columbia Cancer Research Centre, University of British Columbia
Co-authored papers 5
Cyril B Gilks
University of British Columbia
Co-authored papers 4
James M Ford
Stanford University
Co-authored papers 4
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers 4
William D Foulkes
Segal Cancer Centre, Jewish General Hospital
Co-authored papers 4
Carla Oliveira
Co-authored papers 4
Samantha Hansford
The University of British Columbia
Co-authored papers 4
Ian Bosdet
University of British Columbia
Co-authored papers 4
Jacqueline E Schein
Canada British Columbia Cancer Research Centre, University of British Columbia
Co-authored papers 3
Release 1.2